EF Hutton Initiates Artelo Biosciences(ARTL.US) With Buy Rating, Announces Target Price $6
Artelo Biosciences Price Target Announced at $6.00/Share by EF Hutton
Artelo Biosciences Initiated at Buy by EF Hutton
Maxim Group Maintains Artelo Biosciences(ARTL.US) With Buy Rating, Maintains Target Price $5
Optimistic Buy Rating for Artelo Biosciences Amidst Growing Focus on Cancer Cachexia Therapies
Maxim Group Maintains Artelo Biosciences(ARTL.US) With Buy Rating, Maintains Target Price $5
Artelo Biosciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Artelo Biosciences, Maintains $5 Price Target
Buy Rating Affirmed for Artelo Biosciences on Strong Clinical Pipeline and Solid Financial Health
Artelo Biosciences' Drug Portfolio Progress Bolsters Buy Rating: Analyst Vernon Bernardino Forecasts Significant Clinical Milestones
H.C. Wainwright Maintains Artelo Biosciences(ARTL.US) With Buy Rating, Maintains Target Price $5
Artelo Biosciences' Promising Pipeline and Preclinical Advancements Underpin Buy Rating
Artelo Biosciences Analyst Ratings
Artelo Biosciences Analyst Ratings
Artelo Biosciences: Strong Buy Rating on Clinical Advancement and Solid Financials
Artelo Biosciences Analyst Ratings
Buy Rating on Artelo Biosciences: Strong Pipeline and Market Potential
Promising Developments in Artelo Biosciences' Cancer Therapies Drive Buy Rating Recommendation
HC Wainwright & Co. Reiterates Buy on Artelo Biosciences, Maintains $5 Price Target
Artelo Biosciences Analyst Ratings
No Data
No Data